Johnson & Johnson on Wednesday said it received U.S. and European regulatory approval for its Veritas Vision System, which is aimed at improving the phacoemulsification technique used in cataract surgery.
The New Brunswick, N.J., healthcare giant said the Veritas system features technologies that allow surgeons to guide through any lens density with less surge and more stability, adding that it also provides advancements in ergonomics to further enhance usability during cataract surgery.
Phacoemulsification, the most common cataract surgery technique, allows ophthalmologists to emulsify and remove the eye's internal lens when it has become cloudy from cataracts, Johnson & Johnson said.
The company said it plans a full commercial launch of the Veritas system globally later this year.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.